Table 12.6d

Immunosuppression Use for Maintenance by Regimen

Prior to Discharge, 2000 to 2009

Recipients with Lung Transplants

	Transplant Year
	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009
Functioning Graft at Discharge	859	951	947	1,013	1,107	1,284	1,299	1,359	1,369	1,552
With Immunosuppression Info	855	948	942	1,009	1,097	1,268	1,293	1,337	1,357	1,547
CyA	0.1%	0.0%	0.0%	0.0%	0.1%	0.0%	0.1%	0.0%	0.0%	0.0%
Tac	0.1%	0.0%	0.1%	1.0%	0.1%	0.4%	0.1%	0.4%	0.5%	0.3%
--- + MMF/MPA	0.0%	0.1%	0.1%	0.0%	0.0%	0.0%	0.0%	0.1%	0.1%	0.0%
CyA + MMF/MPA	0.5%	0.1%	0.1%	0.2%	0.1%	0.2%	0.1%	0.0%	0.0%	0.1%
Tac + MMF/MPA	0.9%	0.1%	0.1%	0.8%	0.5%	0.6%	1.5%	1.6%	0.8%	1.0%
--- + OtherAntimet	0.0%	0.0%	0.1%	0.0%	0.0%	0.0%	0.0%	0.1%	0.0%	0.0%
CyA + OtherAntimet	0.1%	0.1%	0.3%	0.7%	0.4%	0.1%	0.1%	0.0%	0.0%	0.1%
Tac + OtherAntimet	0.2%	0.2%	0.2%	2.3%	1.5%	0.6%	0.3%	2.0%	0.2%	0.2%
--- + MMF/MPA + OtherAntimet	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.1%	0.0%	0.0%	0.0%
Tac + MMF/MPA + OtherAntimet	0.0%	0.1%	0.0%	0.1%	0.0%	0.1%	0.1%	0.1%	0.0%	0.0%
Tac + MMF/MPA + Siro/Evero	0.0%	0.0%	0.0%	0.0%	0.0%	0.1%	0.1%	0.0%	0.0%	0.0%
--- + Steroids	0.9%	0.7%	0.7%	1.2%	0.5%	1.0%	0.5%	0.8%	0.5%	1.8%
CyA + Steroids	2.9%	2.4%	1.4%	1.2%	1.1%	1.1%	1.5%	0.6%	1.2%	1.4%
Tac + Steroids	1.4%	1.7%	5.7%	6.0%	7.0%	4.8%	4.0%	5.1%	5.9%	8.3%
--- + MMF/MPA + Steroids	0.4%	0.4%	0.2%	0.3%	0.2%	0.8%	0.3%	0.3%	0.5%	0.9%
CyA + MMF/MPA + Steroids	15.4%	17.8%	17.5%	13.6%	10.0%	7.9%	6.4%	2.3%	2.9%	2.6%
Tac + MMF/MPA + Steroids	16.3%	18.8%	25.4%	27.1%	35.3%	43.8%	45.6%	56.2%	58.5%	53.5%
--- + OtherAntimet + Steroids	0.0%	0.5%	0.0%	0.2%	0.4%	0.2%	0.2%	0.4%	0.1%	0.4%
CyA + OtherAntimet + Steroids	39.9%	27.1%	20.7%	16.0%	16.0%	12.2%	7.3%	6.7%	3.8%	3.1%
Tac + OtherAntimet + Steroids	16.0%	20.9%	23.0%	24.9%	23.3%	24.4%	28.5%	21.9%	23.1%	24.7%
--- + Siro/Evero + Steroids	0.0%	0.1%	0.1%	0.2%	0.0%	0.0%	0.0%	0.0%	0.1%	0.0%
CyA + Siro/Evero + Steroids	0.0%	0.1%	0.3%	0.1%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Tac + Siro/Evero + Steroids	0.6%	2.5%	0.1%	0.0%	0.4%	0.2%	0.9%	0.1%	0.1%	0.1%
Other Regimen	4.2%	6.1%	3.7%	4.3%	3.3%	1.5%	2.5%	1.3%	1.5%	1.5%

Source: OPTN/SRTR Data as of October 1, 2010.

Percentages in each column sum to 100 percent.

---: No Calcineurin Inhibitor Use; CyA: Cyclosporine; Tac: Tacrolimus.

MMF: Mycophenolate Mofetil; MPA: Mycophenolate Sodium; Siro: Sirolimus; Evero: Everolimus; OtherAntimet: Antimetabolites excluding MMF and MPA.

"Other Regimen" includes drug combinations that are different from the listed regimens and drugs from the text field entering.